Dose Finding, Safety and Tolerability Study for AC220 to Treat Advanced Solid Tumors

NCT01049893 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: Compound AC220

Sponsor

Daiichi Sankyo